NAS:SIBN (USA)
Business Description
SI-BONE Inc
NAICS : 334510
SIC : 3845
471 El Camino Real, Suite 101, Santa Clara, CA, USA, 95050
Description
SI-BONE Inc is a medical device company, develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. It offers iFuse, an implant system to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that causes lower back pain.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.86 | |||||
| Equity-to-Asset | 0.67 | |||||
| Debt-to-Equity | 0.36 | |||||
| Debt-to-EBITDA | -0.68 | |||||
| Piotroski F-Score | 1/9 | |||||
| Altman Z-Score | 3.98 | |||||
| Beneish M-Score | -2.64 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -26.9 | |||||
| 3-Year EBITDA Growth Rate | -0.5 | |||||
| 3-Year EPS without NRI Growth Rate | 8.1 | |||||
| 3-Year FCF Growth Rate | 10.7 | |||||
| 3-Year Book Growth Rate | 2.7 | |||||
| Future 3-5Y Total Revenue Growth Rate Industry Rank | 18.36 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 82.31 | |||||
| 9-Day RSI | 77.15 | |||||
| 14-Day RSI | 72.4 | |||||
| 6-1 Month Momentum % | -29.68 | |||||
| 12-1 Month Momentum % | -31.59 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 8.9 | |||||
| Quick Ratio | 7.91 | |||||
| Cash Ratio | 6.86 | |||||
| Days Inventory | 362.5 | |||||
| Days Sales Outstanding | 50.85 | |||||
| Days Payable | 126.96 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -11.3 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 87.12 | |||||
| Operating Margin % | -64.77 | |||||
| Net Margin % | -69.37 | |||||
| ROE % | -49.79 | |||||
| ROA % | -35.45 | |||||
| ROIC % | -171.43 | |||||
| ROC (Joel Greenblatt) % | -236.08 | |||||
| ROCE % | -36.03 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 6.15 | |||||
| PB Ratio | 5.38 | |||||
| Price-to-Tangible-Book | 5.66 | |||||
| EV-to-EBIT | -8.42 | |||||
| EV-to-EBITDA | -8.81 | |||||
| EV-to-Forward-EBITDA | -10.98 | |||||
| EV-to-Revenue | 5.44 | |||||
| EV-to-Forward-Revenue | 5.11 | |||||
| EV-to-FCF | -9.19 | |||||
| Price-to-Net-Current-Asset-Value | 6.74 | |||||
| Price-to-Net-Cash | 10.6 | |||||
| Earnings Yield (Greenblatt) % | -11.85 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Gurus Latest Trades with NAS:SIBN
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 95.54 | ||
| EPS (TTM) ($) | -1.97 | ||
| Beta | 1.84 | ||
| Volatility % | 44.26 | ||
| 14-Day RSI | 72.4 | ||
| 14-Day ATR ($) | 0.980832 | ||
| 20-Day SMA ($) | 15.6715 | ||
| 12-1 Month Momentum % | -31.59 | ||
| 52-Week Range ($) | 11.89 - 25.41 | ||
| Shares Outstanding (Mil) | 34.31 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
SI-BONE Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||